Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Verisante Technology, Inc V.VRS

Sector: Healthcare | Sub-Sector: Medical Devices
Alternate Symbol(s):  VRSEF

Verisante Technology Inc is a medical device company. It commercializes systems for the early detection of cancer. Its products are the Verisante Aura(tm) for skin cancer detection & Verisante Core (tm) series for lung, colon & cervical cancer detection.
Price: $0.105 | Change: +$0.005 | %Change: +5.00%
Volume: 59,000 | Day High/Low: 0.105/0.10 | 52 Week High/Low: 0.225/0.08
View modes: 
0 stars

RE:That is too funny

I could not agree more. Guilty of making that very mistake myself 15 years ago but VRS has a better strategy and more depth than I had at the time. When the money ran out we merged with a VSX more
0 stars

That is too funny

Sorry I do not mean to come off so intensely. I just love promising helth tech and worry that sometimes the science gets in the way of the business. In other words we get so caught up in the more
5 stars

RE:So you have read 2 news releases???

Insightful1: why so intense? This is a penny stock is it not? Chill out brother.  rate and reply
0 stars

So you have read 2 news releases???

You have read 2 press releases as DD and your other  comment was to give the devices away. Not much help I am afraid. Suggesting a company that is cash stapped should give  $40,000 medical more
0 stars

RE:That helps

Please read my post of January 15th., then scroll up to BaystreetBrian’s post of February 17th. That may offer you a clue as to just how much DD . Yes I do question your motives for being here, more
0 stars

That helps

So you cannot articulate the merits of Verisante as an investment , You are on this site to question everyone elses motive for being here. I could point out the obvious irony but I won't.  rate and reply
0 stars

RE:My holdings

in a more positive light than yourself....  rate and reply
0 stars

My holdings

Yes I own shares of both Verisante and MedX. I do not own MelaFind. I have read extensively on skin cancer and believe the wait times to see a dermatologist is preventing people from proper care. more
0 stars

RE:Thanks for the insight

Why do you keep saying “we”? Do you hold shares?  rate and reply
1 star

Thanks for the insight

Verisante has a technology that detects the most agressive form of cancer. That was there breakthough product they stated they have put a direct sales team together to sell more
0 stars

RE:How is this great news??

its all about gettig the product out there. Sooner or later something will stick, a door will open and niche will be established. Can't do this sitting in the office complaining. Got to shake the more
5 stars

RE:How is this great news??

Who let this negative ninny in here? Every startup has "poor financials", mid caps and large caps have poor financials.....that suggestion is irrelevant. Reducing the cost by 50% is massive news! more
0.5 stars

How is this great news??

It looks like we loaned the technology to a university in hopes they can work on reducing the price of the scope. That has 2 implications; firstly our device is too expensive to gain market more
5 stars


VANCOUVER, BRITISH COLUMBIA, Feb 18, 2015 (Marketwired via COMTEX) -- Verisante Technology, Inc. (VRS)(otcqx:VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, more
0 stars

RE:How does this affect us?  rate and reply
0 stars

Big Deal for Verisante !,2094160 more
0 stars

How does this affect us?

Feb 16 (Reuters) - Jantar Development SA : * As a part of the reverse merger process, shareholders of MSI Bioscience Sp. z o.o. acquire 4,114,909 of the company's series D shares for 2 zlotys more
5 stars

Brain tumour study  rate and reply
0 stars

Brain tumour study with raman spectroscopy  rate and reply
0 stars

RE:RE:RE:Here's an idea to save Verisante

No, it’s not the craziest idea. The OP of this thread (sharted) I believe, put a few legitimate ideas forward. I was just saying that giving it away didn’t work that well for mela. Some of the OP’ more